Search research articles
Contact Us
Filters
Showing results (41-50 of 196) with videos related to
Page
of 20
Sort By:
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
|
May 23, 2021
Intraoperative thalamocortical tract monitoring via direct cortical recordings during craniotomy
Mirela V Simon, William T Curry, Pamela S Jones, et al.
Neuro-Oncology
|
January 23, 2019
Accelerated progression of IDH mutant glioma after first recurrence
Julie J Miller, Franziska Loebel, Tareq A Juratli, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 5, 2021
Evidence-based recommendations on categories for extent of resection in diffuse glioma
Philipp Karschnia, Michael A Vogelbaum, Martin van den Bent, et al.
Cancer Research
|
October 1, 2020
Local Targeting of NAD<sup>+</sup> Salvage Pathway Alters the Immune Tumor Microenvironment and Enhances Checkpoint Immunotherapy in Glioblastoma
Ming Li, Ameya R Kirtane, Juri Kiyokawa, et al.
Journal of Neuro-Oncology
|
November 5, 2015
The role of neuropathology in the management of patients with diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline
Daniel P Cahill, Andrew E Sloan, Brian V Nahed, et al.
Neurosurgery
|
May 31, 2018
Isocitrate Dehydrogenase Mutations in Low-Grade Gliomas Correlate With Prolonged Overall Survival in Older Patients
Pamela S Jones, Kate T Carroll, Matthew Koch, et al.
Journal of Neuro-Oncology
|
July 23, 2025
Factors associated with cognitive impairment in long-term IDH-mutant glioma survivors
Tyler A Lanman, Hana Gross, Caylin M Faria, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 8, 2024
CDKN2A/B Homozygous Deletion Sensitizes IDH-Mutant Glioma to CDK4/6 Inhibition
Ali M Nasser, Lisa Melamed, Ethan A Wetzel, et al.
Neurosurgical Focus
|
February 1, 2024
Suppression of antitumor immune signatures and upregulation of VEGFA as IDH-mutant gliomas progress to higher grade
Eric P Grewal, Leland G K Richardson, Jing Sun, et al.
Neuro-Oncology
|
July 26, 2020
Sirtuin activation targets IDH-mutant tumors
Julie J Miller, Alexandria Fink, Jack A Banagis, et al.
Page
of 20
Search research articles
Search
Showing results (41-50 of 196) with videos related to
Sort By:
Page
of 20
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
|
May 23, 2021
Intraoperative thalamocortical tract monitoring via direct cortical recordings during craniotomy
Mirela V Simon, William T Curry, Pamela S Jones, et al.
Neuro-Oncology
|
January 23, 2019
Accelerated progression of IDH mutant glioma after first recurrence
Julie J Miller, Franziska Loebel, Tareq A Juratli, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 5, 2021
Evidence-based recommendations on categories for extent of resection in diffuse glioma
Philipp Karschnia, Michael A Vogelbaum, Martin van den Bent, et al.
Cancer Research
|
October 1, 2020
Local Targeting of NAD<sup>+</sup> Salvage Pathway Alters the Immune Tumor Microenvironment and Enhances Checkpoint Immunotherapy in Glioblastoma
Ming Li, Ameya R Kirtane, Juri Kiyokawa, et al.
Journal of Neuro-Oncology
|
November 5, 2015
The role of neuropathology in the management of patients with diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline
Daniel P Cahill, Andrew E Sloan, Brian V Nahed, et al.
Neurosurgery
|
May 31, 2018
Isocitrate Dehydrogenase Mutations in Low-Grade Gliomas Correlate With Prolonged Overall Survival in Older Patients
Pamela S Jones, Kate T Carroll, Matthew Koch, et al.
Journal of Neuro-Oncology
|
July 23, 2025
Factors associated with cognitive impairment in long-term IDH-mutant glioma survivors
Tyler A Lanman, Hana Gross, Caylin M Faria, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 8, 2024
CDKN2A/B Homozygous Deletion Sensitizes IDH-Mutant Glioma to CDK4/6 Inhibition
Ali M Nasser, Lisa Melamed, Ethan A Wetzel, et al.
Neurosurgical Focus
|
February 1, 2024
Suppression of antitumor immune signatures and upregulation of VEGFA as IDH-mutant gliomas progress to higher grade
Eric P Grewal, Leland G K Richardson, Jing Sun, et al.
Neuro-Oncology
|
July 26, 2020
Sirtuin activation targets IDH-mutant tumors
Julie J Miller, Alexandria Fink, Jack A Banagis, et al.
Page
of 20